Home
TNDM
TNDM News

Latest Tandem Diabetes Care Inc. (TNDM) News on April 19, 2025

Reasons to Hold TNDM Stock in Your Portfolio for Now

Zacks

2 days ago

Reasons to Hold TNDM Stock in Your Portfolio for Now

Argus Research

3 days ago

TNDM: Raising target price to $19.00

MT Newswires

4 days ago

RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

StockStory

4 days ago

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

Motley Fool

6 days ago

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction

3 Undervalued Small Caps With Recent Insider Activity Across Regions

Simply Wall St.

8 days ago

3 Undervalued Small Caps With Recent Insider Activity Across Regions

Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?

Zacks

9 days ago

Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last?

MT Newswires

9 days ago

Mizuho Initiates Tandem Diabetes Care at Neutral With $20 Price Target

Argus Research

10 days ago

TNDM: Lowering target price to $17.00

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

Business Wire

15 days ago

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

Morningstar Research

15 days ago

Analyst Report: Tandem Diabetes Care, Inc.

Argus Research

17 days ago

TNDM: Lowering target price to $20.00

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

Zacks

21 days ago

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound?

3 Reasons to Sell TNDM and 1 Stock to Buy Instead

StockStory

24 days ago

3 Reasons to Sell TNDM and 1 Stock to Buy Instead

Argus Research

24 days ago

TNDM: What does Argus have to say about TNDM?

Tandem announces publication of results from trial of Control-IQ+ AID technology

TipRanks

a month ago

Tandem announces publication of results from trial of Control-IQ+ AID technology

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

MedTech Dive

a month ago

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes

Business Wire

a month ago

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes

TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology

Zacks

a month ago

TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

Business Wire

a month ago

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

3 Healthcare Stocks Walking a Fine Line

StockStory

a month ago

3 Healthcare Stocks Walking a Fine Line

Reasons to Hold TNDM Stock in Your Portfolio for Now

Zacks

a month ago

Reasons to Hold TNDM Stock in Your Portfolio for Now

Argus Research

a month ago

TNDM: Lowering target price to $16.00

Investing.com

2 months ago

Bernstein downgrades Tandem Diabetes on market share loss concerns

MT Newswires

2 months ago

Bernstein Downgrades Tandem Diabetes Care to Market Perform From Outperform, $35 Price Target

Loss-Making Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Expected To Breakeven In The Medium-Term

Simply Wall St.

2 months ago

Loss-Making Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Expected To Breakeven In The Medium-Term

Morningstar Research

2 months ago

Analyst Report: Tandem Diabetes Care, Inc.

Tandem Diabetes Crashes 35% As Light Outlook Rattles Pump-Maker's Shares

Investor's Business Daily

2 months ago

Tandem Diabetes Crashes 35% As Light Outlook Rattles Pump-Maker's Shares

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

Zacks

2 months ago

TNDM Stock Falls in Aftermarket Following Q4 Earnings and Revenue Miss

MT Newswires

2 months ago

UBS Adjusts Price Target on Tandem Diabetes Care to $35 From $40, Keeps Neutral Rating

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Tandem Diabetes Care Inc Earnings Call

Tandem Diabetes Care (TNDM) Slid in Q4 Despite Strong Results

Insider Monkey

2 months ago

Tandem Diabetes Care (TNDM) Slid in Q4 Despite Strong Results

MT Newswires

2 months ago

RBC Cuts Price Target on Tandem Diabetes Care to $55 From $65, Keeps Outperform Rating

MT Newswires

2 months ago

Tandem Diabetes Care Q4 Swings to Earnings, Revenue Rises

Tandem Diabetes Care Inc (TNDM) Q4 2024 Earnings Call Highlights: Record Sales Growth and ...

GuruFocus.com

2 months ago

Tandem Diabetes Care Inc (TNDM) Q4 2024 Earnings Call Highlights: Record Sales Growth and ...

Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings

Zacks

2 months ago

Here's What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings

Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Lags Revenue Estimates

Zacks

2 months ago

Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Lags Revenue Estimates

FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes

Medical Device Network

2 months ago

FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes

MT Newswires

2 months ago

Tandem Diabetes Care Says FDA Clears Insulin Delivery Technology for Type 2 Diabetes

Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Zacks

2 months ago

Tandem Diabetes Care (TNDM) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Business Wire

2 months ago

Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Tandem Diabetes (TNDM) Q4 Earnings: What To Expect

StockStory

2 months ago

Tandem Diabetes (TNDM) Q4 Earnings: What To Expect

NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?

Zacks

2 months ago

NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?

Argus Research

2 months ago

TNDM: Lowering target price to $26.00

Tandem Diabetes Care Announces Upcoming Conference Presentations

Business Wire

2 months ago

Tandem Diabetes Care Announces Upcoming Conference Presentations

Argus Research

2 months ago

TNDM: What does Argus have to say about TNDM?

Wealth management platform Prosper secures $4.9m

Private Banker International

3 months ago

Wealth management platform Prosper secures $4.9m

Argus Research

3 months ago

TNDM: Raising target price to $29.00

Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock?

Zacks

3 months ago

Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock?

Argus Research

3 months ago

TNDM: Lowering target price to $28.00

Reasons to Retain TNDM Stock in Your Portfolio for Now

Zacks

3 months ago

Reasons to Retain TNDM Stock in Your Portfolio for Now

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Business Wire

3 months ago

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Argus Research

3 months ago

TNDM: Lowering target price to $29.00

Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?

Zacks

3 months ago

Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?

MT Newswires

3 months ago

Bernstein Adjusts Price Target on Tandem Diabetes Care to $44 From $42, Maintains Outperform Rating

MT Newswires

3 months ago

Tandem Diabetes Care Launches Collaboration With University of Virginia to Develop Insulin Delivery Systems

Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems

Business Wire

3 months ago

Tandem Diabetes Care Enters Multi-Year Research Collaboration with UVA Center for Diabetes Technology for Development of Advanced Insulin Delivery Systems

Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock?

Zacks

3 months ago

Inari Medical (NARI) Soars 30.6%: Is Further Upside Left in the Stock?

Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Trading At A 46% Discount?

Simply Wall St.

4 months ago

Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Trading At A 46% Discount?

Argus Research

4 months ago

TNDM: Raising target price to $29.00

Argus Research

4 months ago

TNDM: What does Argus have to say about TNDM?

TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada

Zacks

4 months ago

TNDM Stock to Gain From t:slim X2 With Dexcom G7 Launch in Canada

Argus Research

4 months ago

TNDM: What does Argus have to say about TNDM?

Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada

Business Wire

4 months ago

Tandem t:slim X2 Insulin Pump Now Compatible with Dexcom G7 CGM in Canada

Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?

Zacks

4 months ago

Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?

Reasons to Retain TNDM Stock in Your Portfolio for Now

Zacks

4 months ago

Reasons to Retain TNDM Stock in Your Portfolio for Now

Argus Research

5 months ago

TNDM: Raising target price to $27.00

Argus Research

5 months ago

TNDM: Raising target price to $24.00

Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In Now

Insider Monkey

5 months ago

Tandem Diabetes Care, Inc. (TNDM): An Oversold Healthcare Stock to Invest In Now

Tandem Diabetes Care Announces Upcoming Conference Presentations

Business Wire

5 months ago

Tandem Diabetes Care Announces Upcoming Conference Presentations

Argus Research

5 months ago

TNDM: Lowering target price to $25.00

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket

Zacks

5 months ago

TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket

Tandem Diabetes price target lowered to $37 from $39 at Baird

TipRanks

5 months ago

Tandem Diabetes price target lowered to $37 from $39 at Baird

Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report

Simply Wall St.

5 months ago

Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report

Morningstar Research

5 months ago

Analyst Report: Tandem Diabetes Care, Inc.

Morningstar Research

5 months ago

Analyst Report: Tandem Diabetes Care, Inc.

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Tandem Diabetes Care Inc Earnings Call

Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

GuruFocus.com

5 months ago

Tandem Diabetes Care Inc (TNDM) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say

Zacks

5 months ago

Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to Say

Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates

Zacks

5 months ago

Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates

Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance

Business Wire

5 months ago

Tandem Diabetes Care Announces Third Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance

MT Newswires

5 months ago

Bernstein Initiates Coverage on Tandem Diabetes Care With Outperform Rating, $42 Price Target

Argus Research

5 months ago

TNDM: What does Argus have to say about TNDM?

Delcath Systems, Inc. (DCTH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

6 months ago

Delcath Systems, Inc. (DCTH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Tandem Diabetes Care Announces Upcoming Conference Participation

Business Wire

6 months ago

Tandem Diabetes Care Announces Upcoming Conference Participation

Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for

Zacks

6 months ago

Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for

Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 14% this week, taking three-year losses to 75%

Simply Wall St.

6 months ago

Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 14% this week, taking three-year losses to 75%

Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround

Zacks

6 months ago

Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround

Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Highlights: Strong Sales Growth and ...

GuruFocus.com

6 months ago

Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Highlights: Strong Sales Growth and ...

Argus Research

6 months ago

TNDM: Lowering target price to $36.00

MT Newswires

6 months ago

--Goldman Sachs Initiates Tandem Diabetes Care at Neutral With $46 Price Target

Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024

Business Wire

7 months ago

Tandem Diabetes Care to Announce Third Quarter 2024 Financial Results on November 6, 2024

Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says

Benzinga

7 months ago

Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says

Investing.com

7 months ago

This pharma stock offers an attractive risk-reward says RBC

Morningstar Research

7 months ago

Analyst Report: Tandem Diabetes Care, Inc.

Why Tandem Diabetes Care Stock Took It on the Chin Tuesday

Motley Fool

7 months ago

Why Tandem Diabetes Care Stock Took It on the Chin Tuesday

t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock

Zacks

7 months ago

t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock

TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU

Zacks

7 months ago

TNDM Stock Likely to Benefit From the t:slim X2-Lyumjev Offering in EU

Tandem secures approval for t:slim X2 insulin pump to use with Lyumjev

Medical Device Network

7 months ago

Tandem secures approval for t:slim X2 insulin pump to use with Lyumjev

Why Tandem Diabetes Care Stock Thrashed the Market Today

Motley Fool

7 months ago

Why Tandem Diabetes Care Stock Thrashed the Market Today

Share on Social Networks: